-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.O2.6 803. Emerging Tools, Techniques and Artificial Intelligence in Hematology: Image-Based Machine Learning in Hematology

Symposia: Emerging Tools, Techniques and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, artificial intelligence (AI), Translational Research, Clinical Research, bioinformatics, emerging technologies, Technology and Procedures, machine learning
Monday, December 11, 2023: 2:45 PM-4:15 PM
Room 6CF (San Diego Convention Center)
Moderators:
Jan Moritz Middeke, MD, Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden and National Center for Tumor Diseases (NCT) Dresden and Niroshan Nadarajah, MLL Munich Leukemia Laboratory
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Andrew Srisuwananukorn, MD1, Giuseppe Gaetano Loscocco2*, Andrew T. Kuykendall, MD3, James M Dolezal, MD4, Raffaella Santi, MD5*, Ling Zhang, MD6, Avani M Singh, MD7*, Paola Guglielmelli, MD, PhD8, Alessandro Maria Vannucchi9, Douglas Tremblay, MD10, Alexander T Pearson, MD, PhD11*, Mohamed E. Salama, MD12,13* and Ronald Hoffman, MD14

1Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Centro Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, Florence, ITA
3Moffitt Cancer Center, Tampa, FL
4Department of Medicine, University of Chicago Comprehensive Cancer Center, Chicago
5Pathology Section, Department of Health Sciences, University of Florence, Florence, Italy
6Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7Department of Hematology Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa
8Centro Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, Florence, Italy
9CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
10Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY
11Department of Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL
12Department of Pathology, University of Texas Health Science Center, San Antonio
13Sonic Healthcare USA, Austin, TX
14Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

3:00 PM

Gianluca Asti, MSc1*, Saverio D'Amico, MSc1*, Nico Curti, PhD2,3*, Gianluca Carlini, PhD2,3*, Elisabetta Sauta, PhD1*, Nicolas Riccardo Derus, PhD4*, Daniele Dall'Olio, PhD4*, Claudia Sala, PhD4*, Lorenzo Dall'Olio, PhD2,3*, Luca Lanino, MD5, Giulia Maggioni, MD1*, Alessia Campagna1*, Marta Ubezio, MD1*, Antonio Russo, MD1*, Gabriele Todisco, MD1*, Cristina Astrid Tentori, MD1*, Pierandrea Morandini, MEng1*, Marilena Bicchieri, PhD1*, Maria Chiara Grondelli, BSc1*, Matteo Zampini, PhD1*, Victor Savevski, MEng1*, Armando Santoro, MD6,7*, Shahram Kordasti, MD, PhD8, Valeria Santini, MD9, Anne Sophie Kubasch, MD10*, Uwe Platzbecker, MD11, Maria Diez-Campelo, MD, PhD12*, Pierre Fenaux, MD, PhD13, Lin-Pierre Zhao, MD13*, Amer M. Zeidan, MBBS, MHS14, Torsten Haferlach, MD, PhD15, Gastone Castellani, PhD4* and Matteo Giovanni Della Porta, MD1,16*

1Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
2Department of Physics and Astronomy, University of Bologna, Bologna, Italy
3Data Science and Bioinformatics Laboratory, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
4University of Bologna, Bologna, Italy
5Humanitas Clinical and Research Center, IRCCS, Rozzano, Milano, Italy
6Humanitas Cancer Center, Rozzano, Mi, Italy
7Humanitas University, Pieve Emanuele and IRCCS Humanitas Research Hospital- Humanitas Cancer Center Rozzano, Milan, Italy
8King's College London, London, United Kingdom
9MDS Unit, DMSC, AOU Careggi, University of Florence, Firenze, Italy
10Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
11Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
12Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
13Saint Louis hospital APHP, Paris, France
14Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
15MLL Munich Leukemia Laboratory, Munich, Germany
16Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy

3:15 PM

Catherine SY Lecat, MBBS1*, Yeman Brhane Hagos, PhD2*, Dominic Patel3*, Anna Mikolajczak1*, Thien-An Tran1*, Lydia Sarah Hui Lee, MD PhD1*, Manuel Rodriguez-Justo3*, Yinyin Yuan, PhD4,5* and Kwee Yong6

1Department of Hematology, UCL Cancer Institute, London, United Kingdom
2Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
3Research Department of Pathology, UCL Cancer Institute, London, United Kingdom
4Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute for Cancer Research, London, United Kingdom
5Centre for Molecular Pathology, The Institute for Cancer Research, London, United Kingdom
6Cancer Institute, University College London, London, United Kingdom

3:30 PM

Chen Zhou1*, Jie Xu, MD PhD2*, Rishab Prakash, BS3*, Carlos P Torres-Cabala, MD4*, Cheng-bang Chen, PhD5*, Kamesh Madduri, PhD1*, Arvind Rao, PhD6*, Greeshma Agasthya, PhD7*, Francisco Vega, MD, PhD8, Dennis O’Malley, MD9*, L. Jeffrey Medeiros, MD10, Soundar Kumara, PhD1* and Swami P. Iyer, MD11

1Penn State University, State College, PA
2Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Dermatopathology, University of Texas MD Anderson, Houston, TX
5University of Miami, Coral Gables, FL
6University of Michigan, Ann Arbor, MI
7Oak Ridge National Laboratory, Oak Ridge, TN
8Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
9NeoGenomics Laboratories, Inc., Aliso Viejo, CA
10Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

3:45 PM

Anna L. Kamysheva, MSc*, Dmitrii V. Fastovets, MSc*, Roman N. Kruglikov, MSc*, Arseniy A. Sokolov, BSc*, Anastasiya S. Fefler, MSc*, Anastasiia A. Bolshakova, MSc*, Anastasia Radko, BSc*, Ilya E. Krauz, MSc*, Sheila T. Yong*, Michael Goldberg, PhD*, Ravshan Ataullakhanov, PhD* and Aleksandr Zaitsev, MSc*

BostonGene, Corp., Waltham, MA

4:00 PM

Yoko Kawamura, PhD1*, Kayoko Nakanishi2*, Yuri Murata1*, Kazuki Teranishi1*, Ryusuke Miyazaki1*, Keisuke Toda, PhD1*, Toru Imai1*, Yasuhiro Kajiwara1*, Keiji Nakagawa1*, Hidemasa Matsuo, PhD2*, Souichi Adachi, MD, PhD2*, Sadao Ota, PhD1,3* and Hidefumi Hiramatsu, MD, PhD4

1ThinkCyte K.K., Tokyo, Japan
2Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3The University of Tokyo, Tokyo, JPN
4Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

*signifies non-member of ASH